Compare IDEXX Laboratories, Inc. (IDXX) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Roblox Corp — how do they compare? IDEXX Laboratories, Inc. trades at $560 (market cap $44.48B), while Roblox Corp trades at $52.85 (market cap $38.13B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap. Which is the better fit depends on your goals.
| IDXX | RBLX | |
|---|---|---|
Market Cap | $44.48B | $38.13B |
Sector | Health | Media |
52-Week High | $766.68 | $141.56 |
52-Week Low | $520.87 | $41.30 |
Enterprise Value | $45.38B | $36.71B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Roblox trades at $54.08, up 4.64% today, showing positive momentum despite a bearish technical signal. The company continues to demonstrate strong revenue growth with $4.89B in 2025, though it remains unprofitable with a -20.69% net margin. Recent product innovation includes the launch of 'Build,' an AI-powered game creation tool, while facing multiple class-action lawsuits alleging securities fraud between October 2025 and April 2026.
While analyst consensus remains positive with a $59.62 price target and 51% buy ratings, investors face significant risks from ongoing litigation and persistent profitability challenges. The stock's high P/B ratio of 85.65 suggests premium valuation despite negative returns on equity, creating a mixed investment case dependent on future margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
